AIM Puts mRNA Covid Vaccine in Investor Crosshairs With New IPO Attempt
Key takeaways:
Vaccine maker AIM has filed for an IPO in Hong Kong, following unsuccessful previous bids in Hong Kong and on Shenzhen’s ChiNext board
The company has three Covid vaccines under development, including an mRNA vaccine expected to hit the market in the fourth quarter
By Fai Pui